نتائج البحث 41-50 من 13457 لعملية البحث عن anti-TNF drugs
The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all ...
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU ... Radioactive drugs, such as lutetium Lu 177 ... A Study of ...
Drugs used in chemotherapy, such as cisplatin and ... The purpose of this study is to compare the usual treatment (radiation therapy ... anti-cancer drugs ( ...
Drugs used in chemotherapy regimens such as UH-3 ... Anti-cancer activity will be assessed every 6 ... This study will compare the use of hypofraction proton ...
Anti-cancer activity will be assessed every 6 ... Drugs used in chemotherapy regimens such as UH-3 ... drugs for the initial WT) and regimen ICE ...
Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual Chemotherapy Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous ...
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
Treatments for T-cell lymphomas may include a "watch and wait" approach, chemotherapy, immunotherapy, radiation therapy, targeted therapy, clinical trials, and ...
Systemic chemotherapy, targeted agents and immunotherapy have largely been ineffective in treatment of LM, in part due to limited CNS/CSF penetration. New ...
... drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab and a standard chemotherapy drug, pegylated liposomal ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.